Hyoscine Butylbromide

Drug Class: Gastrointestinal System Agents
Dosage Form: Injection
Strength: 20mg/ml
Indications/Special comments: Prevention of motion sickness. Prevention of postoperative nausea and vomiting. Oral: Symptomatic treatment of postencephalitis Parkinsonism and paralysis agitans. Treatment of spasticity. Inhibits excessive motility and hypertonus of GI tract in irritable colon syndrome, mild dysentery, diverticulitis, and pylorospasm. Prevention of motion sickness.
Dosage Administration: IV: Adults: One ampoule (20 mg) intramuscularly or intravenously, repeated after half an hour if necessary. Intravenous injection should be performed ‘slowly’, when used in endoscopy this dose may need to be repeated more frequently. Maximum daily dose of 100mg.